Logo

biomarker discovery

Precision for Medicine's QuartzBio Acquires Genomic Data Analytics Firm SolveBio

QuartzBio expects SolveBio's genomics and clinical data analytics technology to accelerate biomarker discovery in pursuit of precision therapies.

Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer

This clinical study, called Sculptor, is the first research to emerge from a strategic collaboration between the companies on oncology therapeutics.

Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement

The companies aim to use Caris' genomic and transcriptomic testing to identify biomarkers that can improve chances of success for the novel drug.

Owkin, Stanford Medicine Collaborate on AI-Driven Lung Cancer, Mesothelioma Biomarker Discovery

The French bioinformatics firm will analyze molecular and other multimodal data in search of new cancer therapeutics.

Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer

The program, funded by Singapore's National Research Foundation, aims to identify Epstein-Barr virus strains associated with NPC in Southeast Asian populations. 

Sep 23, 2022

Study Finds Metabolomic States Informing Common Disease Risk

Sep 7, 2022

Head and Neck Cancer Treatment Targets, Biomarkers Unearthed in Cell Model Analyses

Aug 8, 2022

Baylor Researchers Apply Graph Analysis to Identify Novel Alzheimer's Gene Candidates
Premium

Jul 11, 2022

Immune Checkpoint Blockade Response Linked to Recurrent Mutations in Genes, Pathways

Jun 30, 2022

Analysis of Tumor Mutation, Treatment Data Across Cancers Points to Predictive Biomarkers

Jun 28, 2022

Boehringer Ingelheim, BiomX Embark on New Inflammatory Bowel Disease Biomarker Discovery Project

Jun 22, 2022

Biosignatures Show Potential For Predicting Cancer Risk in Non-Alcoholic Liver Disease Patients

Jun 1, 2022

Startup Quantori Seeks to Accelerate Multiomic R&D for Pharma, Biotech, Hospitals
Premium

May 11, 2022

SAS, BC Platforms Partnership Expected to Open New Markets, Improve Data Integration
Premium

Apr 28, 2022

Owkin, ADC Therapeutics Team on AI-Based Biomarker Discovery

Apr 13, 2022

Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research

Apr 12, 2022

New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia
Premium

Apr 7, 2022

Pangea Biomed Builds on RNA-Based Drug Matching to Expand Precision Oncology Opportunities
Premium

Apr 6, 2022

Psychiatric Disease Blood Markers Proposed From Biochemical, GWAS Profiles

Mar 7, 2022

Epigenetic Biomarkers May Help Assess Preterm Birth Risk
Premium

Jan 26, 2022

COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study

Oct 26, 2021

Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities

Oct 14, 2021

Genialis Expands Partnership With Slovenia's BioLab

Oct 1, 2021

UK Researchers Show Cytotoxic T-Cell Level Predicts Melanoma Immunotherapy Response

Sep 24, 2021

T Cell Repertoire Emerging as Potential Predictor in Neoadjuvant Lung Cancer Immunotherapy
Premium

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.